BioCardia
BCDA
23 hedge funds and large institutions have $3.98M invested in BioCardia in 2023 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 7 reducing their positions, and 3 closing their positions.
0.18% less ownership
Funds ownership: 0.87% → 0.69% (-0.18%)
8% less funds holding
Funds holding: 25 → 23 (-2)
18% less capital invested
Capital invested by funds: $4.87M → $3.98M (-$889K)
57% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 7
59% less call options, than puts
Call options by funds: $283K | Put options by funds: $684K
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vontobel Holding
Zurich,
Switzerland
|
+$35.2K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$23.5K |
| 3 |
Renaissance Technologies
New York
|
+$3.32K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2.22K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
-$191K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$153K |
| 3 |
FM
Family Management
New York
|
-$143K |
| 4 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
-$46.1K |
| 5 |
Millennium Management
New York
|
-$24K |
BCDA Hedge Fund Activity: Q1 2023 in Review
23 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in BioCardia (BCDA) for Q1 2023, worth a combined $3.98M — down 18% from $4.87M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of BCDA and 1 opened new positions — a net loss of 2 holders — while 7 trimmed existing stakes and 3 added.
The largest buyer was Vontobel Holding, opening a new position worth an estimated $35.2K. The largest seller was AIGH Capital Management, cutting an estimated $191K.
- 23 institutional investors held BioCardia (BCDA) as of Q1 2023, down from 25 in Q4 2022.
- Funds reported $3.98M of BioCardia stock for Q1 2023, down 18% quarter-over-quarter.
- 1 fund opened new BioCardia positions in Q1 2023 and 3 closed out, a net change of -2 holders.
- The largest BioCardia buyer in Q1 2023 was Vontobel Holding, an estimated $35.2K added.
- The largest BioCardia seller in Q1 2023 was AIGH Capital Management, an estimated $191K sold.
Based on aggregated 13F filings for Q1 2023.